Shenzhen New Industries Biomedical Engineering's H1 Profit Jumps 20%, Operating Income Up 19%

MT Newswires Live08-23

Shenzhen New Industries Biomedical Engineering (SHE:300832) recorded a net profit attributable to shareholders of 903.1 million yuan in the first half of the year, jumping 20.4% from the year-ago profit of almost 750 million yuan, according to a Friday disclosure on the Shenzhen Stock Exchange.

Earnings per share rose 20.5% year on year to 1.15 yuan from 0.95 yuan.

The Chinese biomedical technology company generated an operating income worth 2.21 billion yuan, up 18.5% from 1.87 billion yuan in the previous year.

Shares of the company rose less than 2% in recent trade.

Price (RMB): ¥63.85, Change: ¥+0.92, Percent Change: +1.46%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment